Correlation Between Cardio Diagnostics and Design Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and Design Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and Design Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and Design Therapeutics, you can compare the effects of market volatilities on Cardio Diagnostics and Design Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of Design Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and Design Therapeutics.
Diversification Opportunities for Cardio Diagnostics and Design Therapeutics
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Cardio and Design is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and Design Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Design Therapeutics and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with Design Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Design Therapeutics has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and Design Therapeutics go up and down completely randomly.
Pair Corralation between Cardio Diagnostics and Design Therapeutics
Given the investment horizon of 90 days Cardio Diagnostics Holdings is expected to generate 2.73 times more return on investment than Design Therapeutics. However, Cardio Diagnostics is 2.73 times more volatile than Design Therapeutics. It trades about 0.24 of its potential returns per unit of risk. Design Therapeutics is currently generating about 0.08 per unit of risk. If you would invest 29.00 in Cardio Diagnostics Holdings on September 12, 2024 and sell it today you would earn a total of 123.00 from holding Cardio Diagnostics Holdings or generate 424.14% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Cardio Diagnostics Holdings vs. Design Therapeutics
Performance |
Timeline |
Cardio Diagnostics |
Design Therapeutics |
Cardio Diagnostics and Design Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cardio Diagnostics and Design Therapeutics
The main advantage of trading using opposite Cardio Diagnostics and Design Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, Design Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Design Therapeutics will offset losses from the drop in Design Therapeutics' long position.Cardio Diagnostics vs. Immix Biopharma | Cardio Diagnostics vs. Cns Pharmaceuticals | Cardio Diagnostics vs. Sonnet Biotherapeutics Holdings | Cardio Diagnostics vs. Zura Bio Limited |
Design Therapeutics vs. Monte Rosa Therapeutics | Design Therapeutics vs. Werewolf Therapeutics | Design Therapeutics vs. Ikena Oncology | Design Therapeutics vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |